Preliminary Report of a Phase II Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (Mylotarag)Given in Combination with Cytarabine in Patients with Acute Myelogenous Leukemia

Reviewer: Tracy d'Entremont, MD
Ultima Vez Modificado: 7 de diciembre del 2002

Translation for this article does not exist


Catherine and Finn
by OncoLink Editorial Team
December 01, 2015